Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
Legend Biotech Corporation announced robust first-quarter 2026 results, highlighted by a 62% increase in CARVYKTI® net trade sales compared to Q1 2025, driven by expanded availability across 18 global markets. The company improved manufacturing efficiency, achieved significant milestones under the Janssen collaboration, and reported a substantial r…